The ORPEA group, one of the main world leaders in long-term care (nursing homes, post-acute and
rehabilitation hospitals, psychiatric hospitals, and homecare services), today announces its revenue for
the 2017 financial year ended on 31 December.
In 2017, 15 years on from its IPO, ORPEA reported revenue above its guidance at €3,138 million. It
represents a substantial increase of 10.5%, or close to €300 million in additional revenue. This solid
performance, consistent over the past 15 years, was again driven by a combination of:
– a healthy organic growth of 5.4%, underpinned by the excellent performance of mature facilities,
the ramp-up in facilities opened over the past two years and the opening of 1,900 new beds
(through new builds and restructuration) during the year,
– a dynamic external growth, leading to the acquisitions of Anavita in the Czech Republic,
Dr. Dr. Wagner in Austria, Spitex in Switzerland and independent facilities.
The international business again strongly contributed to revenue growth. In only three years, revenue
generated outside France tripled from €450 million in 2014 to over €1.35 billion in 2017, representing an
average annual growth rate of 45%.
In 2017, this fast-paced business development and growth went hand in hand with increasing profitability.
In 2018, ORPEA will open another new 2,500 beds, including 85% outside France, representing
approximately 20 facilities and extensions. In line with ORPEA’s longstanding strategy, these facilities
located in areas with strong purchasing power, including Europe’s major cities, such as Paris (16th
arrondissement), Prague, Berlin, Milan, Zurich and Veyrier, will meet the highest standards of care and
ORPEA again expects a year of active recruitment and job creation thanks to the ongoing opening of new
facilities and strengthening of organisational management. Close to 2,000 new jobs will be created in
Europe, including approximately 400 in France. Most of these jobs are sustainable and cannot be
transferred abroad. They offer substantial career opportunities as a result of the Group’s ambitious
training policy with the creation, in particular, of many diplomas in partnership with renowned
For 2018, ORPEA securely forecasts revenues of €3,400 million, an increase of 8.3% driven by a consistent
solid organic growth and acquisitions
The Group is looking at a number of selective acquisition
opportunities in several countries.
Yves Le Masne, Chief Executive Officer of ORPEA:
“Building on the commitment of our employees to deliver high-quality services worldwide, our loyal
management team and our sound financial flexibility, we will continue to deliver profitable growth in
2018: selective acquisitions, revenue of €3,400 million already secured, and robust profitability, with an
EBITDA margin (as a % of revenue) equal to or above its 2017 level.
Our tremendous potential for creating value comes from:
– the significant additions to our growing pipeline of beds under construction and redevelopment,
which will fuel our organic growth in the future,
– our numerous attractive acquisition projects,
– an organisation and information system geared for international expansion.
We are now in a remarkably good position and are uniquely placed to accelerate our international
expansion and become the world leader in long-term care.
Source : Company